GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
2AEP | 2AEP | An epidemiologically significant epitope of a 1998 influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. | |
2AEQ | Q80DL0 | An epidemiologically significant epitope of a 1998 influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. | |
2AEQ | 2AEQ | An epidemiologically significant epitope of a 1998 influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. | |
4GT7 | P01854 | An engineered disulfide bond reversibly traps the IgE-Fc3-4 in a closed, non-receptor binding conformation | |
4RA0 | Q14393-2 | An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis | |
4RA0 | P30530 | An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis | |
7UPY | P0DTC2 | An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion | |
7UPY | 7UPY | An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion | |
6C5V | K9US75 | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | |
6C5V | Q1HVF6 | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | |
6C5V | P0C6Z5 | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | |
6C5V | 6C5V | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | |
2FGL | O30700 | An alkali thermostable F/10 xylanase from alkalophilic Bacillus sp. NG-27 | |
3VVK | Q3ITX1 | An M-like Reaction State of the azide-bound purple form of pharaonis halorhodopsin | |
8IKX | Q9LYJ5 | An Arabidopsis polygalacturonase PGLR | |
7EXK | M2RAI8 | An AA9 LPMO of Ceriporiopsis subvermispora | |
1MW3 | Q9ZEU2 | Amylosucrase soaked with 1M sucrose | |
1MW1 | Q9ZEU2 | Amylosucrase soaked with 14mM sucrose. | |
1MW2 | 4107260 | Amylosucrase soaked with 100mM sucrose | |
1MVY | 4107260 | Amylosucrase mutant E328Q co-crystallized with maltoheptaose. | |
1MW0 | 4107260 | Amylosucrase mutant E328Q co-crystallized with maltoheptaose then soaked with maltoheptaose. | |
1ZS2 | 4107260 | Amylosucrase Mutant E328Q in a ternary complex with sucrose and maltoheptaose | |
6M6T | A0A0E1EIJ0 | Amylomaltase from Streptococcus agalactiae in complex with acarbose | |
4S3R | P15977 | Amylomaltase MalQ from Escherichia coli in complex with the pseudo-heptasaccharide acarviosine-glucose-acarbose | |
4S3Q | P15977 | Amylomaltase MalQ from Escherichia coli in complex with maltose | |
8F2B | P63092 | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
8F2B | P62873 | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
8F2B | O60896 | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
8F2B | P59768 | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
8F2B | 8F2B | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
8F2B | P30988 | Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45 | |
6GYA | A0A3P8MUS3 | Amylase in complex with branched ligand | |
6GXV | A0A3P8MUS3 | Amylase in complex with acarbose | |
4WKM | K8QNC4 | AmpR effector binding domain from Citrobacter freundii bound to UDP-MurNAc-pentapeptide | |
4WKM | 4WKM | AmpR effector binding domain from Citrobacter freundii bound to UDP-MurNAc-pentapeptide | |
2HDS | P00811 | AmpC beta-lactamase in complex with 4-Methanesulfonylamino benzoic acid | |
1UA0 | 1UA0 | Aminofluorene DNA adduct at the pre-insertion site of a DNA polymerase | |
8ZCL | P0DOX5 | Ambient Temperature Crystal Structure of Fc Fragment of Human IgG1 from Biosimilar VEGF-Trap | |
8BYI | 8BYI | Alvinella pompejana nicotinic acetylcholine receptor Alpo4 in complex with CHAPS(Alpo4_CHAPS) | |
8BX5 | 8BX5 | Alvinella pompejana nicotinic acetylcholine receptor Alpo4 in apo state (dataset 1) | |
8BXE | 8BXE | Alvinella pompejana nicotinic acetylcholine receptor Alpo4 in apo state (Alpo4_comb dataset 3) | |
8BXF | 8BXF | Alvinella pompejana nicotinic acetylcholine receptor Alpo4 in apo state (Alpo4_apo, dataset 1) | |
8BXD | 8BXD | Alvinella pompejana nicotinic acetylcholine receptor Alpo4 in apo state (Alpo4_LMNG_Serotonin dataset 4) | |
8BXB | 8BXB | Alvinella pompejana nicotinic acetylcholine receptor Alpo in apo state (dataset 2) | |
4N5V | P66992 | Alternative substrates of Mycobacterium tuberculosis anthranilate phosphoribosyl transferase | |
4N93 | P66992 | Alternative substrates of Mycobacterium tuberculosis anthranilate phosphoribosyl transferase | |
2RIU | Q5A3V6 | Alternative models for two crystal structures of Candida albicans 3,4-dihydroxy-2-butanone 4-phosphate synthase- alternate interpreation | |
9H28 | P29837 | Alternative conformation LGTV with TBEV prME | |
9H28 | A0A7M3UFX3 | Alternative conformation LGTV with TBEV prME | |
7ROQ | O95477 | Alternative Structure of Human ABCA1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024